On October 6, after decades of pharmacy advocates fighting at the federal and state levels to better control drug pricing and protect the viability of community pharmacies, the Justices of the United States Supreme Court heard oral arguments in Rutledge v PCMA, which may finally determine whether states can control terrible PBM business practices.
Scott J. Knoer, MS, PharmD, FASHP, APhA EVP and CEO